Europe Genetic Testing market was valued at US$ 2,472.0 Mn in 2020 and it is projected to reach at US$ 4,262.4 Mn by 2027, at a CAGR of 8.5% during the forecast period.


Major factors accounting for this growth include the increase in incidences of genetic, infectious & chronic diseases, reduction in prices of genetic sequencing, rising adoption of precision medicine diagnostic techniques. Genetic testing is defined as medical test which detect changes in proteins, genes or chromosomes. The test results are able to confirm a speculated underlying genetic condition or aid in determining an individual’s chance of developing/ passing on a genetic disorder.


Get Sample Copy of this Report @


Europe Genetic Testing market report has provided key-insights on several factors which are poising as drivers for the Europe Genetic Testing during the forecast period. The report also consists different volume trends, value aspects of the products & the pricing history of the same. Several primary factors driving substantial growth in the global Europe Genetic Testing include mounting global population, different relevant government regulations introduced & their impact and the demand & supply mechanism functioning in the Europe Genetic Testing.


Market Drivers: Increasing focus of government for genetic testing awareness


The growing focus by governments of several countries, to regulate& create awareness regarding genetic tests, has successfully resulted in the faster adoption of these tests worldwide. The rise in Research & Development funding, with the strong market presence by major players in the market, has created a strong entry barrier for new entrants. The increasing innovation in product design, improvement in quality, and strong distribution partnerships are key factors to retain a competitive edge in the market.


Get discount on this report @


Market Key Players


Various key players are listed in this report such as Abbott Laboratories, Illumina Inc., Eurofins Scientific, Qiagen, Elitech Group, Thermo Fischer Scientific, Centogene AG, Blueprint Genetics, 23andMe Inc., F. Hoffmann-La Roche Ltd, etc.


Market Taxonomy


By Type

  • Carrier Testing
  • Diagnostic Testing
  • Newborn Screening
  • Predictive & Presymptomatic Testing
  • Prenatal Testing
  • Others


By Disease

  • Alzheimer’s Disease
  • Cancer
  • Cystic Fibrosis
  • Sickle Cell Anemia
  • Duchenne Muscular Dystrophy
  • Thalassemia
  • Huntington’s Disease
  • Others


By Technology

  • Cytogenetic Testing
  • Biochemical Testing
  • Molecular Testing


By Country

  • Germany
  • UK
  • France
  • Turkey
  • Switzerland
  • Norway
  • Sweden
  • Spain
  • Italy
  • Denmark
  • Finland
  • Iceland
  • Poland
  • Luxembourg
  • Netherlands
  • Belgium


Browse Full Research Report @


About Us

QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition. 

Tags: Europe Genetic Testing, Europe Genetic Testing Industry, Europe Genetic Testing Market Size, Europe Genetic Testing Market Shares, Europe Genetic Testing Market Growth, Europe Genetic Testing Market

See Campaign:
Contact Information:
Contact Person: Vishal Thakur Research Support Specialist QualiKet Research 6060 N Central Expy #500, TX 75204, U.S.A Email: [email protected] Website:

Reportedtimes, Financial Content, iCN Internal Distribution, Research Newswire, English


Contact Information:

Contact Person:

Vishal Thakur

Research Support Specialist

QualiKet Research

6060 N Central Expy #500, TX 75204, U.S.A

Email: [email protected]